The Partnership to Fight Infectious Disease (Pfid)
Advocacy for issues related to infectious like AMR
Based in DC
AI Overview
With $750K in lobbying spend across 17 quarterly filings, The Partnership to Fight Infectious Disease (Pfid) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $120K |
| 2023 | $210K |
| 2024 | $240K |
| 2025 | $180K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that The Partnership to Fight Infectious Disease (Pfid) disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
The need for Congress to pass financial incentives for the purpose of encouraging the development of new and novel antibiotics as well as other steps to address AMR.
The need for Congress to pass new financial incentives for the purpose of encouraging new and novel antibiotic development as well as other steps to combat Antimicrobial Resistance (AMR)
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.